Geoffrey Hartzler, interventional cardiology pioneer, has died after a battle with cancer at the age of 65.
Advertisement
Latest News
-
Friday, May 25, 2012 | Source: Journal of the American College of Cardiology
-
By L.A. McKeown
Patients with acute coronary syndromes (ACS) who undergo coronary artery bypass graft (CABG) surgery have lower mortality if they have been receiving…
-
Thursday, May 24, 2012 | Source: Journal of the American Medical Association
-
By Yael Maxwell
Cracking, peeling, and other damage to polymer surfaces can be seen following delivery balloon expansion in all 4 drug eluting stents (DES) currently…
-
Wednesday, May 23, 2012 | Source: Radiology
-
By Alison Palkhivala
Second generation contrast enhanced ultrasound is nearly as effective as computed tomographic angiography (CTA) for detecting endoleaks in patients…
-
Wednesday, May 23, 2012 | Source: Archives of Internal Medicine
-
By Kim Dalton
After revascularization, stress echocardiography can help identify high risk asymptomatic patients, but it provides no better guidance for patient…
-
Tuesday, May 22, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—Findings on novel devices and imaging techniques, as well as other practice changing results, were presented at last week's EuroPCR 2012,…
-
Tuesday, May 22, 2012 | Source: Journal of the American College of Cardiology
-
By L.A. McKeown
Patients’ CYP2C19 genotype plays a significant role in responsiveness to clopidogrel in both the acute and maintenance phases of antiplatelet therapy,…
-
Monday, May 21, 2012 | Source: Circulation
-
By Kim Dalton
Drug eluting stents (DES) substantially reduce target vessel revascularization (TVR) following percutaneous coronary intervention (PCI) compared with…
-
Friday, May 18, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—Two large randomized trials presented May 17 at EuroPCR 2012 showed nearly identical results for biodegradeable polymer drug eluting…
-
Friday, May 18, 2012 | Source: EuroPCR 2012
-
By Jason Kahn
PARIS, France—Results from 2 observational studies presented May 15 at EuroPCR are consistent with a growing body of literature demonstrating improved…
-
Friday, May 18, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—New data from the SOURCE XT registry show that a second generation transcatheter aortic valve replacement (TAVR) device achieves the highest…
News From Industry
-
Tuesday, May 15, 2012
ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent
-
Tuesday, May 15, 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
-
Tuesday, May 15, 2012
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
-
Tuesday, May 15, 2012
Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
-
Monday, May 14, 2012
Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System
|